- Home
- HALO vs VNO Comparison
HALO vs VNO Comparison
Compare HALO & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- VNO
- Stock Information
- Founded
- HALO 1998
- VNO 1946
- Country
- HALO United States
- VNO United States
- Employees
- HALO N/A
- VNO N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- VNO Real Estate Investment Trusts
- Sector
- HALO Health Care
- VNO Real Estate
- Exchange
- HALO Nasdaq
- VNO Nasdaq
- Market Cap
- HALO 7.4B
- VNO 7.0B
- IPO Year
- HALO N/A
- VNO N/A
- Fundamental
- Price
- HALO $52.02
- VNO $39.63
- Analyst Decision
- HALO Buy
- VNO Hold
- Analyst Count
- HALO 9
- VNO 11
- Target Price
- HALO $63.56
- VNO $38.00
- AVG Volume (30 Days)
- HALO 3.1M
- VNO 1.3M
- Earning Date
- HALO 05-06-2025
- VNO 05-05-2025
- Dividend Yield
- HALO N/A
- VNO 1.87%
- EPS Growth
- HALO 55.40
- VNO 248.25
- EPS
- HALO 3.76
- VNO 0.52
- Revenue
- HALO $1,084,306,000.00
- VNO $1,929,890,000.00
- Revenue This Year
- HALO $24.79
- VNO N/A
- Revenue Next Year
- HALO $22.65
- VNO $5.12
- P/E Ratio
- HALO $13.83
- VNO $75.54
- Revenue Growth
- HALO 25.64
- VNO 2.98
- 52 Week Low
- HALO $41.28
- VNO $22.42
- 52 Week High
- HALO $70.51
- VNO $46.63
- Technical
- Relative Strength Index (RSI)
- HALO 39.78
- VNO 61.90
- Support Level
- HALO $47.50
- VNO $38.63
- Resistance Level
- HALO $69.94
- VNO $40.73
- Average True Range (ATR)
- HALO 3.52
- VNO 1.16
- MACD
- HALO -1.49
- VNO 0.34
- Stochastic Oscillator
- HALO 19.64
- VNO 84.17
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.